5F-BZO-POXIZID is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC).
Synthetic cannabinoids have caused adverse events, including deaths. Closely related analogue BZO-HEXOXIZID (MDA 19) was synthesized and studied in the late 2000’s by scientists at the University of Texas M. D. Anderson Cancer Center.
BZO-HEXOXIZID is reported to be a potent and selective cannabinoid receptor 2 (CB2) agonist.
NPS Discovery announced three newly identified novel psychoactive substances in October 2021. 5F-BZO-POXID, and BZO-HEXOXIZID (aka MDA 19) were detected in plant-like materials sold as typical synthetic cannabinoid products. View each of their monographs here.